Centene Corp. Files 2023 Annual Report on Form 10-K

Ticker: CNC · Form: 10-K · Filed: 2024-02-20T00:00:00.000Z

Sentiment: neutral

Topics: Centene, CNC, 10-K, Annual Report, Healthcare

TL;DR

<b>Centene Corporation has filed its 2023 annual report (10-K) detailing its financial performance and business operations for the fiscal year ending December 31, 2023.</b>

AI Summary

CENTENE CORP (CNC) filed a Annual Report (10-K) with the SEC on February 20, 2024. Centene Corporation filed its 2023 Form 10-K on February 20, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal business is described as Hospital & Medical Service Plans. Centene Corporation is incorporated in Delaware. The company's headquarters are located at 7700 Forsyth Blvd., St. Louis, MO.

Why It Matters

For investors and stakeholders tracking CENTENE CORP, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Centene's financial health, operational strategies, and risk factors for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future outlook. As a major player in the health insurance industry, Centene's annual report offers insights into market trends, regulatory impacts, and the company's competitive positioning within the healthcare sector.

Risk Assessment

Risk Level: medium — CENTENE CORP shows moderate risk based on this filing. The company operates in the highly regulated health insurance market, facing potential impacts from changes in government healthcare policies and reimbursement rates, which could affect its financial stability.

Analyst Insight

Investors should review Centene's detailed financial statements and risk factors in the 10-K to understand its performance and potential challenges in the evolving healthcare landscape.

Key Numbers

Key Players & Entities

FAQ

When did CENTENE CORP file this 10-K?

CENTENE CORP filed this Annual Report (10-K) with the SEC on February 20, 2024.

What is a 10-K filing?

A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by CENTENE CORP (CNC).

Where can I read the original 10-K filing from CENTENE CORP?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by CENTENE CORP.

What are the key takeaways from CENTENE CORP's 10-K?

CENTENE CORP filed this 10-K on February 20, 2024. Key takeaways: Centene Corporation filed its 2023 Form 10-K on February 20, 2024.. The filing covers the fiscal year ending December 31, 2023.. The company's principal business is described as Hospital & Medical Service Plans..

Is CENTENE CORP a risky investment based on this filing?

Based on this 10-K, CENTENE CORP presents a moderate-risk profile. The company operates in the highly regulated health insurance market, facing potential impacts from changes in government healthcare policies and reimbursement rates, which could affect its financial stability.

What should investors do after reading CENTENE CORP's 10-K?

Investors should review Centene's detailed financial statements and risk factors in the 10-K to understand its performance and potential challenges in the evolving healthcare landscape. The overall sentiment from this filing is neutral.

How does CENTENE CORP compare to its industry peers?

Centene Corporation operates within the health insurance sector, providing a wide range of managed care services. The industry is characterized by significant regulatory oversight and evolving healthcare policies.

Are there regulatory concerns for CENTENE CORP?

As a health insurer, Centene is subject to extensive federal and state regulations governing health plans, including those related to Medicare and Medicaid. Changes in these regulations can significantly impact operations and profitability.

Industry Context

Centene Corporation operates within the health insurance sector, providing a wide range of managed care services. The industry is characterized by significant regulatory oversight and evolving healthcare policies.

Regulatory Implications

As a health insurer, Centene is subject to extensive federal and state regulations governing health plans, including those related to Medicare and Medicaid. Changes in these regulations can significantly impact operations and profitability.

What Investors Should Do

  1. Review Centene's detailed financial statements for the fiscal year ended December 31, 2023.
  2. Analyze the risk factors section to understand potential challenges and their impact on the company.
  3. Assess management's discussion and analysis of financial condition and results of operations for strategic insights.

Key Dates

Year-Over-Year Comparison

This filing is the annual report for the fiscal year ended December 31, 2023, and provides updated financial and operational information compared to previous filings.

From the Filing

0001071739-24-000037.txt : 20240220 0001071739-24-000037.hdr.sgml : 20240220 20240220163420 ACCESSION NUMBER: 0001071739-24-000037 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 127 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 24654073 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-K 1 cnc-20231231.htm 10-K cnc-20231231 0001071739 2023 FY FALSE http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent P3Y P1Y P1Y 0001071739 2023-01-01 2023-12-31 0001071739 2023-06-30 iso4217:USD 0001071739 2024-02-16 xbrli:shares 0001071739 2023-12-31 0001071739 2022-12-31 iso4217:USD xbrli:shares 0001071739 us-gaap:HealthCarePremiumMember 2023-01-01 2023-12-31 0001071739 us-gaap:HealthCarePremiumMember 2022-01-01 2022-12-31 0001071739 us-gaap:HealthCarePremiumMember 2021-01-01 2021-12-31 0001071739 us-gaap:ServiceMember 2023-01-01 2023-12-31 0001071739 us-gaap:ServiceMember 2022-01-01 2022-12-31 0001071739 us-gaap:ServiceMember 2021-01-01 2021-12-31 0001071739 2022-01-01 2022-12-31 0001071739 2021-01-01 2021-12-31 0001071739 us-gaap:CommonStockMember 2021-12-31 0001071739 us-gaap:CommonStockMember 2020-12-31 0001071739 us-gaap:CommonStockMember 2023-12-31 0001071739 us-gaap:CommonStockMember 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2020-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2021-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001071739 us-gaap:RetainedEarningsMember 2020-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2020-12-31 0001071739 2020-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001071739 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-12-31 0001071739 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-12-31 0001071739 us-

View on Read The Filing